Connection

Robert Wilson to Humans

This is a "connection" page, showing publications Robert Wilson has written about Humans.
Connection Strength

0.206
  1. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab. 2007 Apr; 90(4):414-21.
    View in: PubMed
    Score: 0.011
  2. Monogenic low renin hypertension. Trends Endocrinol Metab. 2005 Apr; 16(3):92-7.
    View in: PubMed
    Score: 0.009
  3. Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2005 Feb; 18(2):133-42.
    View in: PubMed
    Score: 0.009
  4. In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 2004 May; 89(5):2024-7.
    View in: PubMed
    Score: 0.009
  5. Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis. Clin Epigenetics. 2023 02 17; 15(1):25.
    View in: PubMed
    Score: 0.008
  6. Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab. 2001 Dec; 86(12):5651-7.
    View in: PubMed
    Score: 0.007
  7. Apparent mineralocorticoid excess. Trends Endocrinol Metab. 2001 Apr; 12(3):104-11.
    View in: PubMed
    Score: 0.007
  8. Establishment and genomic characterization of a sporadic malignant peripheral nerve sheath tumor cell line. Sci Rep. 2021 03 11; 11(1):5690.
    View in: PubMed
    Score: 0.007
  9. Differential DNA Methylation Landscape in Skin Fibroblasts from African Americans with Systemic Sclerosis. Genes (Basel). 2021 01 20; 12(2).
    View in: PubMed
    Score: 0.007
  10. Prevalence of mild apparent mineralocorticoid excess in Mennonites. J Clin Endocrinol Metab. 1999 Dec; 84(12):4735-8.
    View in: PubMed
    Score: 0.006
  11. Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci U S A. 1999 Oct 26; 96(22):12790-7.
    View in: PubMed
    Score: 0.006
  12. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia. J Clin Endocrinol Metab. 1999 Sep; 84(9):3129-34.
    View in: PubMed
    Score: 0.006
  13. Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers. Oncogene. 2020 01; 39(1):50-63.
    View in: PubMed
    Score: 0.006
  14. ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms. Cell Commun Signal. 2019 07 10; 17(1):74.
    View in: PubMed
    Score: 0.006
  15. Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations. J Clin Endocrinol Metab. 1999 Jan; 84(1):378-81.
    View in: PubMed
    Score: 0.006
  16. A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci U S A. 1998 Aug 18; 95(17):10200-5.
    View in: PubMed
    Score: 0.006
  17. Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11?-hydroxysteroid dehydrogenase type 2 deficiency. Proc Natl Acad Sci U S A. 2017 12 26; 114(52):E11248-E11256.
    View in: PubMed
    Score: 0.006
  18. Complementary feature selection from alternative splicing events and gene expression for phenotype prediction. Bioinformatics. 2016 09 01; 32(17):i421-i429.
    View in: PubMed
    Score: 0.005
  19. A novel mutation in HSD11B2 causes apparent mineralocorticoid excess in an Omani kindred. Ann N Y Acad Sci. 2016 07; 1376(1):65-71.
    View in: PubMed
    Score: 0.005
  20. Systems analysis of the prostate transcriptome in African-American men compared with European-American men. Pharmacogenomics. 2016 07; 17(10):1129-1143.
    View in: PubMed
    Score: 0.005
  21. Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death. Oncotarget. 2016 Jun 14; 7(24):36138-36153.
    View in: PubMed
    Score: 0.005
  22. Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA. BMC Genomics. 2016 Mar 31; 17:263.
    View in: PubMed
    Score: 0.005
  23. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia. J Steroid Biochem Mol Biol. 2017 01; 165(Pt A):51-56.
    View in: PubMed
    Score: 0.005
  24. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERa in SUM-44 breast cancer cells and is associated with ERa over-expression in breast cancer. Mol Oncol. 2016 06; 10(6):850-65.
    View in: PubMed
    Score: 0.005
  25. FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia. 2014 Oct; 16(10):801-13.
    View in: PubMed
    Score: 0.005
  26. Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Mol Oncol. 2015 Feb; 9(2):527-43.
    View in: PubMed
    Score: 0.005
  27. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55.
    View in: PubMed
    Score: 0.004
  28. Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2013 Feb 12; 110(7):2611-6.
    View in: PubMed
    Score: 0.004
  29. Isolated mild clitoral hypertrophy may reveal 46,XY disorders of sex development in infancy due to 17?HSD-3 defect confirmed by molecular analysis. Gynecol Endocrinol. 2011 Nov; 27(11):890-4.
    View in: PubMed
    Score: 0.003
  30. CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children. J Clin Res Pediatr Endocrinol. 2009; 1(3):116-28.
    View in: PubMed
    Score: 0.003
  31. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2007 Jan; 92(1):137-42.
    View in: PubMed
    Score: 0.003
  32. Two novel mutations found in a patient with 17alpha-hydroxylase enzyme deficiency. J Clin Endocrinol Metab. 2006 Oct; 91(10):4179-82.
    View in: PubMed
    Score: 0.003
  33. Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency). J Mol Diagn. 2005 May; 7(2):236-46.
    View in: PubMed
    Score: 0.002
  34. The natural history and genotype-phenotype nonconcordance of HLA identical siblings with the same mutations of the 21-hydroxylase gene. J Pediatr Endocrinol Metab. 2005 Feb; 18(2):143-53.
    View in: PubMed
    Score: 0.002
  35. Nonclassic 21-hydroxylase deficiency in Croatia. J Pediatr Endocrinol Metab. 2004 Feb; 17(2):157-64.
    View in: PubMed
    Score: 0.002
  36. Hypertension and adrenal disorders. Curr Hypertens Rep. 2003 Dec; 5(6):498-504.
    View in: PubMed
    Score: 0.002
  37. Resistance to multiple steroids in two sisters. J Steroid Biochem Mol Biol. 2001 Jan-Mar; 76(1-5):161-6.
    View in: PubMed
    Score: 0.002
  38. Profile of the pediatric endocrine clinic at New York-Presbyterian Hospital, New York Weill Cornell Center. J Clin Endocrinol Metab. 1999 Dec; 84(12):4444-9.
    View in: PubMed
    Score: 0.002
  39. Resistance to several steroids in two sisters. J Clin Endocrinol Metab. 1999 Dec; 84(12):4454-64.
    View in: PubMed
    Score: 0.002
  40. Intrauterine growth retardation associated with maternal uniparental disomy for chromosome 6 unmasked by congenital adrenal hyperplasia. Pediatr Res. 1999 Nov; 46(5):510-3.
    View in: PubMed
    Score: 0.002
  41. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol. 1999 Apr-Jun; 69(1-6):19-29.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.